Literature DB >> 25109332

Geranylgeranylation signals to the Hippo pathway for breast cancer cell proliferation and migration.

W Mi1, Q Lin2, C Childress1, M Sudol3, J Robishaw1, C H Berlot1, M Shabahang4, W Yang1.   

Abstract

Protein geranylgeranylation (GGylation) is an important biochemical process for many cellular signaling molecules. Previous studies have shown that GGylation is essential for cell survival in many types of cancer. However, the molecular mechanism mediating the cell survival effect remains elusive. In this report, we show that the Hippo pathway mediates GGylation-dependent cell proliferation and migration in breast cancer cells. Blockade of GGylation enhanced phosphorylation of Mst1/2 and Lats1, and inhibited YAP and TAZ activity and the Hippo-YAP/TAZ pathway-dependent transcription. The effect of GGylation blockade on inhibition of breast cancer cell proliferation and migration is dependent on the Hippo-YAP/TAZ signaling, in which YAP appears to regulate cell proliferation and TAZ to regulate cell migration. Furthermore, GGylation-dependent cell proliferation is correlated with the activity of YAP/TAZ in breast cancer cells. Finally, Gγ and RhoA are the GGylated proteins that may transduce GGylation signals to the Hippo-YAP/TAZ pathway. Taken together, our studies have demonstrated that the Hippo-YAP/TAZ pathway is essential for GGylation-dependent cancer cell proliferation and migration.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25109332     DOI: 10.1038/onc.2014.251

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  62 in total

1.  Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity.

Authors:  T Scott Reid; Kimberly L Terry; Patrick J Casey; Lorena S Beese
Journal:  J Mol Biol       Date:  2004-10-15       Impact factor: 5.469

2.  A family of G protein βγ subunits translocate reversibly from the plasma membrane to endomembranes on receptor activation.

Authors:  Deepak Kumar Saini; Vani Kalyanaraman; Mariangela Chisari; Narasimhan Gautam
Journal:  J Biol Chem       Date:  2007-06-20       Impact factor: 5.157

3.  Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth.

Authors:  Samuel C Falsetti; De-an Wang; Hairuo Peng; Dora Carrico; Adrienne D Cox; Channing J Der; Andrew D Hamilton; Saïd M Sebti
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

4.  Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study.

Authors:  C Denoyelle; M Vasse; M Körner; Z Mishal; F Ganné; J P Vannier; J Soria; C Soria
Journal:  Carcinogenesis       Date:  2001-08       Impact factor: 4.944

Review 5.  Regulation of the Hippo pathway and implications for anticancer drug development.

Authors:  Hyun Woo Park; Kun-Liang Guan
Journal:  Trends Pharmacol Sci       Date:  2013-09-16       Impact factor: 14.819

6.  Activated Cdc42-associated kinase 1 is a component of EGF receptor signaling complex and regulates EGF receptor degradation.

Authors:  Feng Shen; Qiong Lin; Yan Gu; Chandra Childress; Wannian Yang
Journal:  Mol Biol Cell       Date:  2006-12-20       Impact factor: 4.138

7.  Genomic analysis of metastasis reveals an essential role for RhoC.

Authors:  E A Clark; T R Golub; E S Lander; R O Hynes
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

8.  O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy.

Authors:  Wenyi Mi; Yuchao Gu; Cuifang Han; Haiyan Liu; Qiong Fan; Xinling Zhang; Qi Cong; Wengong Yu
Journal:  Biochim Biophys Acta       Date:  2011-01-19

9.  3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1).

Authors:  U Laufs; D Marra; K Node; J K Liao
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

Review 10.  Lysophospholipid receptor activation of RhoA and lipid signaling pathways.

Authors:  Sunny Yang Xiang; Stephanie S Dusaban; Joan Heller Brown
Journal:  Biochim Biophys Acta       Date:  2012-09-15
View more
  42 in total

1.  The E3 ubiquitin ligase NEDD4 is an LC3-interactive protein and regulates autophagy.

Authors:  Aiqin Sun; Jing Wei; Chandra Childress; John H Shaw; Ke Peng; Genbao Shao; Wannian Yang; Qiong Lin
Journal:  Autophagy       Date:  2017-01-13       Impact factor: 16.016

Review 2.  The 2016 John J. Abel Award Lecture: Targeting the Mechanical Microenvironment in Cancer.

Authors:  Hannah E Majeski; Jing Yang
Journal:  Mol Pharmacol       Date:  2016-10-14       Impact factor: 4.436

3.  Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer.

Authors:  T Ando; D Charindra; M Shrestha; H Umehara; I Ogawa; M Miyauchi; T Takata
Journal:  Oncogene       Date:  2017-09-18       Impact factor: 9.867

4.  Arhgef7 promotes activation of the Hippo pathway core kinase Lats.

Authors:  Emad Heidary Arash; Ki Myung Song; Siyuan Song; Ahmed Shiban; Liliana Attisano
Journal:  EMBO J       Date:  2014-11-25       Impact factor: 11.598

Review 5.  The interplay between cell signalling and the mevalonate pathway in cancer.

Authors:  Peter J Mullen; Rosemary Yu; Joseph Longo; Michael C Archer; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2016-08-26       Impact factor: 60.716

Review 6.  Regulation of the Hippo pathway in cancer biology.

Authors:  Sungho Moon; So Yeon Park; Hyun Woo Park
Journal:  Cell Mol Life Sci       Date:  2018-03-30       Impact factor: 9.261

Review 7.  Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer.

Authors:  Fa-Xing Yu; Bin Zhao; Kun-Liang Guan
Journal:  Cell       Date:  2015-11-05       Impact factor: 41.582

8.  The Hippo-YAP/TAZ pathway mediates geranylgeranylation signaling in breast cancer progression.

Authors:  Qiong Lin; Wannian Yang
Journal:  Mol Cell Oncol       Date:  2016-03-16

9.  Mechanical cues control mutant p53 stability through a mevalonate-RhoA axis.

Authors:  Eleonora Ingallina; Giovanni Sorrentino; Rebecca Bertolio; Kamil Lisek; Alessandro Zannini; Luca Azzolin; Luisa Ulloa Severino; Denis Scaini; Miguel Mano; Fiamma Mantovani; Antonio Rosato; Silvio Bicciato; Stefano Piccolo; Giannino Del Sal
Journal:  Nat Cell Biol       Date:  2017-12-18       Impact factor: 28.824

Review 10.  YAP/TAZ as therapeutic targets in cancer.

Authors:  Francesca Zanconato; Giusy Battilana; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Curr Opin Pharmacol       Date:  2016-06-02       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.